Transcranial Direct Current Stimulation for Chronic Pain

This trial aims to determine if Transcranial Direct Current Stimulation (tDCS) can reduce chronic pain for participants in a specialized mental health program. Participants will undergo short, daily tDCS sessions for two weeks to assess any changes in pain levels and quality of life. It suits individuals already in the program who frequently experience significant pain and have a primary care or pain management doctor. As an unphased trial, this study provides participants the chance to explore a novel approach to managing chronic pain, potentially enhancing their quality of life.

Yes, you may need to stop taking certain medications to join the trial. Specifically, you cannot use sodium channel blockers, certain antidepressants, anti-epileptic medications, calcium channel blockers, or N-Methyl-D-aspartate receptor antagonists.

Research has shown that Transcranial Direct Current Stimulation (tDCS) is generally safe for people. A large review of 162 clinical trials found that tDCS is safe for individuals with various types of chronic pain. Most participants did not experience serious side effects. Some reported mild tingling or itching where the device touched their skin. This suggests that tDCS is a safe option for managing chronic pain.¹²³⁴⁵

Transcranial Direct Current Stimulation (tDCS) is unique because it offers a non-invasive way to manage chronic pain by using a mild electrical current to stimulate specific areas of the brain. Unlike traditional pain treatments like opioids or NSAIDs, which focus on alleviating symptoms, tDCS aims to modulate brain activity, potentially altering the pain perception itself. Researchers are excited about this treatment because it has the potential to provide pain relief without the side effects commonly associated with medications, and it can be administered in short, daily sessions, offering a more convenient option for patients.

This trial will evaluate the effectiveness of transcranial direct current stimulation (tDCS) for chronic pain. Studies have shown that tDCS can significantly reduce chronic pain, with some individuals experiencing reductions of up to 40%. It has proven effective for conditions such as fibromyalgia, migraines, and nerve-related pain. Some research also suggests that combining tDCS with other treatments, like exercise, enhances results. Overall, tDCS appears to be a promising and non-invasive option for managing chronic pain. Participants in this trial will receive tDCS alongside an accelerated Behavioral Health Program to assess their combined effectiveness.¹⁵⁶⁷⁸